Controversies in Breast Cancer: Use of ctDNA to Tailor Systemic Adjuvant / Post-neoadjuvant Therapies (Part 2)

Controversies in Breast Cancer: Use of ctDNA to Tailor Systemic Adjuvant / Post-neoadjuvant Therapies (Part 2)

0% Complete

Course Content

Credits

  • AMA PRA Category 1 Credit™Non-CME

Course Details

Duration
0.00 hour
Released
May 14, 2025
Last Review
May 14, 2025
Expires
May 14, 2028

Faculty & Disclosure

Faculty

Joyce O’Shaughnessy, MD

Disclosure

Joyce O’Shaughnessy, MD discloses no such relationships exist

Accreditation

NA